Drägerwerk AG & Co. KGaA (XETRA:DRW8) — Stock Price

€93.20 EUR
▲ 1.08% today

Drägerwerk AG & Co. KGaA (XETRA:DRW8) is currently trading at €93.20 EUR, up 1.08% today. Over the past 52 weeks, shares have ranged between €51.00 and €93.20. This page tracks Drägerwerk AG & Co. KGaA's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Drägerwerk AG & Co. KGaA market cap and net worth.

Drägerwerk AG & Co. KGaA (DRW8) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Drägerwerk AG & Co. KGaA's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Drägerwerk AG & Co. KGaA Income Statement — Revenue, Profit & Earnings by Year

Drägerwerk AG & Co. KGaA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €3.37 Billion €3.34 Billion €3.05 Billion €3.33 Billion €3.41 Billion
Cost of Revenue €1.86 Billion €1.90 Billion €1.81 Billion €1.79 Billion €1.80 Billion
Gross Profit €1.51 Billion €1.44 Billion €1.24 Billion €1.54 Billion €1.61 Billion
Research & Development €333.07 Million €338.95 Million €343.48 Million €328.58 Million €289.60 Million
SG&A €275.88 Million €240.91 Million €258.66 Million €261.11 Million €248.12 Million
Total Operating Expenses €1.33 Billion €1.30 Billion €1.32 Billion €1.26 Billion €1.20 Billion
Operating Income €167.32 Million €150.95 Million €-79.76 Million €280.89 Million €411.53 Million
EBITDA €351.68 Million €340.62 Million €62.62 Million €285.37 Million €422.86 Million
EBIT €205.83 Million €150.95 Million €-81.83 Million €280.89 Million €411.53 Million
Interest Expense €23.62 Million €31.10 Million €17.98 Million €39.80 Million €39.76 Million
Income Before Tax €175.39 Million €120.20 Million €-102.41 Million €236.65 Million €360.17 Million
Income Tax Expense €50.63 Million €24.02 Million €-38.77 Million €82.38 Million €110.28 Million
Net Income €124.41 Million €93.72 Million €-64.56 Million €154.23 Million €250.16 Million

Drägerwerk AG & Co. KGaA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Drägerwerk AG & Co. KGaA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €3.09 Billion €3.09 Billion €3.11 Billion €3.18 Billion €3.31 Billion
Total Current Assets €1.88 Billion €1.87 Billion €1.90 Billion €1.99 Billion €2.15 Billion
Cash & Equivalents €223.47 Million €260.00 Million €302.47 Million €439.44 Million €492.23 Million
Short-term Investments €24.72 Million €7.40 Million €4.21 Million €137.94 Million €146.85 Million
Net Receivables €857.80 Million €889.71 Million €735.72 Million €658.19 Million €767.63 Million
Inventory €654.34 Million €654.74 Million €705.69 Million €621.98 Million €624.76 Million
Property, Plant & Equipment €548.98 Million €571.28 Million €587.89 Million €516.25 Million €503.74 Million
Goodwill €312.15 Million €311.24 Million €311.81 Million €310.98 Million €307.96 Million
Total Liabilities €1.56 Billion €1.69 Billion €1.79 Billion €1.92 Billion €2.27 Billion
Total Current Liabilities €978.48 Million €1.02 Billion €1.22 Billion €934.91 Million €1.15 Billion
Long-term Debt €204.35 Million €257.71 Million €162.21 Million €184.84 Million €157.81 Million
Net Debt €172.12 Million €199.43 Million €59.49 Million €-91.43 Million €-121.48 Million
Total Stockholder Equity €1.54 Billion €1.41 Billion €1.32 Billion €1.26 Billion €1.03 Billion
Retained Earnings €1.18 Billion €1.07 Billion €969.30 Million €924.97 Million €716.47 Million

Drägerwerk AG & Co. KGaA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Drägerwerk AG & Co. KGaA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €167.31 Million €189.68 Million €-144.23 Million €384.89 Million €459.98 Million
Capital Expenditures €63.78 Million €68.21 Million €86.86 Million €110.34 Million €114.94 Million
Free Cash Flow €103.52 Million €121.47 Million €-231.09 Million €274.54 Million €345.04 Million
Investing Cash Flow €-43.39 Million €-67.34 Million €36.83 Million €-109.92 Million €-263.08 Million
Financing Cash Flow €-161.38 Million €-154.56 Million €-29.38 Million €-334.64 Million €114.25 Million
Dividends Paid €-33.16 Million €-3.68 Million €3.68 Million €4.05 Million €5.45 Million
Stock-Based Compensation — €196.00K €-137.99 Million €-174.91 Million €-192.13 Million
Depreciation €147.00 Million €148.55 Million €141.94 Million €143.68 Million €118.76 Million
Change in Cash €-41.36 Million €-39.60 Million €-134.19 Million €-51.58 Million €301.02 Million

Drägerwerk AG & Co. KGaA Earnings History — EPS Actual vs. Analyst Estimates

Track Drägerwerk AG & Co. KGaA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 28, 2026 — — —
Oct 29, 2025 1.91 — —
Jul 29, 2025 0.60 — —
Apr 30, 2025 4.05 — —
Mar 05, 2025 — — —
Oct 29, 2024 0.78 — —
Jul 25, 2024 1.42 — —
Apr 25, 2024 0.38 — —